Synthesis and <i>In-Vitro</i> Cytotoxicity of (E)-N,2,3-Triarylacrylamide Derivatives as Analogs of Combretastatin A-4
作者:Kun-Ming Jiang、Xiao-Li Dai、Ke Li、Di Wu、Ji-Hong Zhang、Yi Jin、Jun Lin
DOI:10.2174/1573406410666141226132926
日期:2015.6.30
A new series of (E)-N,2,3-triarylacrylamide derivatives were designed and
synthesized as potent anticancer agents. Cytotoxicity of the 26 target compounds was
evaluated in vitro against six cancer cell lines (HCT116, A549, MDA-MB-468, HepG2, SKNMC and SK-OV-3) by Sulforhodamine
B colorimetric assay. The most promising compound, 4h, was as potent as the reference drug cisplatin
(DDP). Preliminary structure–activity relationship (SAR) data provided guidance for further design and discovery of (E)-
N,2,3-triarylacrylamide scaffold anticancer agents.
研究人员设计并合成了一系列新的(E)-N,2,3-三芳基丙烯酰胺衍生物,作为强效抗癌剂。通过磺基罗丹明 B 比色法,体外评估了 26 种目标化合物对六种癌细胞株(HCT116、A549、MDA-MB-468、HepG2、SKNMC 和 SK-OV-3)的细胞毒性。最有希望的化合物 4h 与参考药物顺铂(DDP)具有同样的药效。初步的结构-活性关系(SAR)数据为进一步设计和发现(E)-N,2,3-三芳基丙烯酰胺支架抗癌剂提供了指导。